The correlations between the genetic basis of PZA resistance and the pyrazinamidase activity

W. J. Su, A. P. Tsou, C. Y. Huang, R. P. Perng (Taipei, Taiwan)

Source: Annual Congress 2001 - Molecular associations with TB
Session: Molecular associations with TB
Session type: Thematic Poster Session
Number: 2039
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. J. Su, A. P. Tsou, C. Y. Huang, R. P. Perng (Taipei, Taiwan). The correlations between the genetic basis of PZA resistance and the pyrazinamidase activity. Eur Respir J 2001; 16: Suppl. 31, 2039

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017
Year: 2017



Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to fluoroquinolones of different generations
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011

Usefulness of a new molecular method to detect fluoroquinolones, kanamycin, capreomycin and ethambutol resistance in TB clinical isolates and direct specimens
Source: Annual Congress 2010 - Tuberculosis: from bench to bedside
Year: 2010


Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011


Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


The effects of drug resistance phenotype on proliferation of Mycobacterium tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

The prevalence of pyrazinamide resistance in multidrug resistant tuberculosis cases in the Netherlands
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012


Dependending on drug resistance character of bacteriostatic blood activity at time polychemotherapy against of M. tuberculosis strains isolated from patients
Source: Eur Respir J 2002; 20: Suppl. 38, 613s
Year: 2002

Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020

The structural and functional study of colistin resistance enzyme MCR-1
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017

Rapid genotypic assays for detection the rifampin and isoniazid resistance in M. tuberculosis strains and clinical specimens in Moldova
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010

Diagnostic of sensitivity mycobacterium tuberculosis strains to isoniazid and rifampicin by simultaneous identification of mutations in rpoB, katG, inhA and ahpC-oxyR genes with biological microchips
Source: Eur Respir J 2006; 28: Suppl. 50, 379s
Year: 2006

In-vitro and in-vivo activity of rifampicin and rifabutin against multi-drug-resistant strains of mycobacterium tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 567s
Year: 2002

Minimal inhibitory concentrations (MIC) of first line drugs in multidrug resistant strains of M. tuberculosis (MDR-TB)
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay
Source: Eur Respir J 2013; 41: 1163-1171
Year: 2013



Efficacy of anti-tuberculosis therapy with INH, RIF and Bedaquiline in mice with different genetic susceptibility to the infection
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use
Source: Eur Respir J, 50 (6) 1701633; 10.1183/13993003.01633-2017
Year: 2017



Detection of mutations associated with isoniazid and rifampicin resistance in M. tuberculosis isolates from Kazakhstan
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010